HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Affirms Previous AHA Conclusions, Issues Seven Final Safety Reports

This article was originally published in The Rose Sheet

Executive Summary

A 1998 safety assessment for alpha hydroxy acids holds up despite an increase in ingredient use and concentration, the Cosmetic Ingredient Review Expert Panel said at its Dec. 9 meeting.

You may also be interested in...



CIR Expert Panel Announces New Blood Ahead Of 161st Meeting

Expect new faces in coming meetings of the US-based CIR’s Expert Panel for Cosmetic Ingredient Safety, which may tackle reviews of prostaglandin analogs and skin-lightening kojic acid on top of its usual slate of programmed safety assessments.

CIR Panel To Consider Re-Reviewing AHA Safety As Use Rises

With use of alpha hydroxy acids in personal-care products on the upswing, the Cosmetic Ingredient Review Expert Panel will revisit the ingredient group’s safety report and consider re-opening a review at its next meeting.

Walmart Exceeds Priority Chemical Reduction Targets

Walmart Inc., which aimed for a 10% reduction in use of priority chemicals in beauty, personal care and household cleaning products sold in stores by 2022, is years ahead of its goal.

Latest News
See All
UsernamePublicRestriction

Register

RS018874

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel